LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹98 Cr | ₹101 Cr | ₹100 Cr | ₹89 Cr | ₹95 Cr |
What is the latest Operating Profit of LINCOLN PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹98 Cr |
| Mar2025 | ₹101 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹95 Cr |
How is Operating Profit of LINCOLN PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹98 Cr | -3.75 | |
| Mar2025 | ₹101 Cr | 1.58 | |
| Mar2024 | ₹100 Cr | 12.00 | |
| Mar2023 | ₹89 Cr | -6.58 | |
| Mar2022 | ₹95 Cr | - | |
Compare Operating Profit of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,015.1 Cr | -0.9% | -10.1% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -0.9% |
-10.1% |
-3.3% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses